Chen Kang, Zhang Song, Jiao Jinghua, Zhao Shan
Department of Ophthalmology, The First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
China Medical University, Shenyang, Liaoning, People's Republic of China.
J Inflamm Res. 2021 Dec 20;14:7079-7090. doi: 10.2147/JIR.S347955. eCollection 2021.
Lung cancer is characterized by high morbidity and mortality rates, and its occurrence is associated with many types of cell death. As a new form of regulated cell death, ferroptosis is an iron- dependent pattern of cell death and characterized by lethal accumulation of lipid-based reactive oxygen species (ROS), which is different from apoptosis, necrosis and autophagy at both the morphological and biochemical levels. It plays an important role in the development of lung cancer and induction of ferroptosis in lung cancer cells has become a new strategy for anti- lung cancer treatment. However, a few reviews summarized ferroptosis and its role in lung cancer has not been elucidated, and the precise mechanism of ferroptosis modeling lung cancer has not yet been revealed till date. Herein, we review the latest literature on the process of ferroptosis regarding lung cancer, including basic molecular or biology mechanistic studies both in vivo and in vitro, as well as human studies with a more translational or clinical approach. This review provides a practical, concise and updated outline on the mechanisms and therapeutic strategies in lung cancer with ferroptosis alterations. Looking ahead, further studies are required to uncover the possible modulatory relationship between ferroptosis and lung cancer.
肺癌具有高发病率和高死亡率的特点,其发生与多种类型的细胞死亡有关。作为一种新的程序性细胞死亡形式,铁死亡是一种铁依赖性的细胞死亡模式,其特征是脂质活性氧(ROS)的致命性积累,在形态和生化水平上都与凋亡、坏死和自噬不同。它在肺癌的发展中起重要作用,诱导肺癌细胞发生铁死亡已成为一种新的抗肺癌治疗策略。然而,很少有综述总结铁死亡及其在肺癌中的作用,迄今为止,铁死亡塑造肺癌的确切机制尚未揭示。在此,我们综述了关于肺癌铁死亡过程的最新文献,包括体内和体外的基础分子或生物学机制研究,以及采用更具转化性或临床方法的人体研究。本综述提供了关于肺癌中铁死亡改变的机制和治疗策略的实用、简明且最新的概述。展望未来,需要进一步研究以揭示铁死亡与肺癌之间可能的调节关系。